PerpEquities

Johnson & Johnson (JNJ) balance sheet

NYSE · Healthcare · Drug Manufacturers - General · 141,700 employees · CEO Joaquin Duato

Price
$273.20 -0.73%
Market cap
$658B
Enterprise value
$685B
Last report
Q3 '26 filed 2026-10-21
Next report
2027-01-26 EPS est. $2.91

At the end of Q3 '26 Johnson & Johnson (JNJ) held $17.2B in cash and short-term investments against $44.7B of debt incl. leases. Total assets $197B, total liabilities $116B, shareholders' equity $81.5B.

Balance sheet

Balance sheetTrendQ4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Assets
Cash & equivalents$21.9B$25.5B$24.9B$20B$24.1B$38.5B$18.6B$18.2B$19.7B$21.7B$20.4B$16.9B
Short-term investments$1.07B$745M$597M$317M$417M$307M$303M$331M$393M$363M$336M$318M
Receivables$19.4B$14.9B$15.8B$16.2B$18.9B$16B$17.8B$17.6B$17.2B$17.7B$19B$19B
Inventory$11.2B$11.4B$12.2B$12.6B$12.4B$12.7B$13.4B$14.1B$14.2B$14.6B$15.1B$15.4B
Other current assets$0$4.46B$4.38B$4.18B$0$4.09B$4.36B$4.29B$4.15B$4.82B$0$4.76B
Current assets$53.5B$57B$57.8B$53.2B$55.9B$71.6B$54.5B$54.6B$55.6B$59.2B$59.8B$56.4B
Property, plant & equipment (net)$19.9B$19.6B$19.7B$20.5B$20.5B$20.9B$21.9B$53.4B$23.2B$54.7B$23.6B$24.1B
Goodwill$36.6B$36.6B$44.3B$44.8B$44.2B$44.5B$48.1B$48B$48.8B$48.6B$48.5B$48.5B
Intangible assets$34.2B$34.3B$39.7B$39.5B$37.6B$36.8B$49.8B$48.7B$50.4B$49.1B$48.2B$46.7B
Deferred tax assets$9.28B$10.3B$9B$9.35B$10.5B$8.49B$6.8B$6.67B$6.87B$6.73B$6.73B$6.75B
Other non-current assets$14.2B$14.1B$10.5B$10.9B$11.4B$11.5B$12.2B-$18.6B$14.4B-$17.3B$14.3B$15.1B
Non-current assets$114B$115B$123B$125B$124B$122B$139B$138B$144B$142B$141B$141B
Total assets$168B$172B$181B$178B$180B$194B$193B$193B$199B$201B$201B$197B
Liabilities
Accounts payable$9.63B$8.17B$8.85B$8.95B$10.3B$9.55B$9.46B$9.63B$12B$10.5B$9.22B$9.32B
Accrued expenses$26.2B$26.5B$28.1B$29.9B$26.1B$26.7B$28.2B$29B$27.7B$25.8B$32.8B$35.3B
Short-term debt$3.45B$8.55B$9.86B$4.46B$5.98B$13.9B$11.5B$6.39B$8.5B$17.5B$11.7B$8.85B
Taxes payable$2.99B$3.32B$4.31B$4.83B$3.77B$4.22B$1.67B$1.93B$0$1.09B$1.05B$1.98B
Other current liabilities$3.99B$2.18B$2.84B$3.62B$4.13B$2.55B$3.3B$3.97B$4.53B$2.91B$90M$0
Current liabilities$46.3B$48.7B$53.9B$51.8B$50.3B$56.9B$54.2B$50.9B$54.1B$57.7B$54.9B$55.5B
Long-term debt$25.9B$25.1B$31.6B$31.3B$30.7B$38.4B$39.2B$39.4B$39.4B$37.5B$37.3B$35.8B
Deferred tax liabilities$3.19B$3.17B$2.64B$2.95B$2.45B$2.43B$3.8B$5.99B$6.79B$7.01B$6.61B$4.84B
Other non-current liabilities$23.4B$25B$21.3B$22.1B$25.2B$17.9B$17.7B$17.3B$17.3B$17.5B$17.2B$19.8B
Non-current liabilities$52.5B$53.2B$55.6B$56.4B$58.3B$58.7B$60.7B$62.7B$63.5B$62B$61.2B$60.4B
Total liabilities$98.8B$102B$110B$108B$109B$116B$115B$114B$118B$120B$116B$116B
Equity
Common stock & paid-in capital$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B$3.12B
Retained earnings$154B$153B$155B$155B$156B$163B$165B$167B$169B$169B$172B$168B
Accumulated other comprehensive income-$12.5B-$10.8B-$11.3B-$12.5B-$11.7B-$11.7B-$14.3B-$15.2B-$14.9B-$14.8B-$14B-$13.8B
Shareholders' equity$68.8B$70B$71.5B$70.2B$71.5B$78.1B$78.5B$79.3B$81.5B$81.2B$85B$81.5B
Debt
Total debt (incl. leases)$29.3B$33.6B$41.5B$35.8B$36.6B$52.3B$50.8B$45.8B$47.9B$55B$49B$44.7B
Net debt (debt - cash)$7.47B$8.16B$16.6B$15.8B$12.5B$13.8B$32.2B$27.6B$28.2B$33.3B$28.6B$27.7B

Standardised by Financial Modeling Prep from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.

Cash, investments and debt

quarter ends

The other statements

Sources

Statements, segment revenue, metrics, estimates: Financial Modeling Prep. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-27, 10-Q 2026-06-28, 10-Q 2026-03-29, 10-K 2025-12-28, 10-Q 2025-09-28, 10-Q 2025-06-29, 10-Q 2025-03-30, 10-K 2024-12-29, 10-Q 2024-09-29

Data as of 2026-11-01